Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Ambiq Micro, Inc.NYSE: AMBQ
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $25.06M rose 59.3% year over year, ahead of the +6.9% change in trailing-twelve-month revenue. Sequentially, it rose 20.8% from the prior quarter.
Context
- Revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $141.15M (+94.7%) for the fiscal year ending Dec 2026, a step up from the -4.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $25.06M+20.8% QoQ
- Last fiscal yearDec 2025
- $72.51M-4.7% YoY
- LTMMar 2026
- $81.84M+6.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +59.3% | +76.3% | +17.0 pp |
| 1 year | -4.7% | +94.7% | +99.3 pp |
| 3-year CAGR | — | +52.1% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 72.51M USD
- Year-over-year change
- -4.7%
- 5-year CAGR
- +7.3%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 72.51M | -4.7% |
| FY2024 | 2024-12-31 | 76.07M | +16.1% |
| FY2023 | 2023-12-31 | 65.54M | — |
| FY2021 | 2021-12-31 | 91.01M | +78.5% |
| FY2020 | 2020-12-31 | 50.97M | — |
Revenue vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of +6.9% is the 8th highest of 11, against a peer median of +17.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $712.5M USD | -6.4% | +9.8% | |
| LTM Apr 2026 | $318.15M USD | +0.3% | +1.1% | |
| LTM Mar 2026 | $302.14M USD | +18.8% | -8.4% | |
| LTM Mar 2026 | $248.72M USD | +16.8% | +18.9% | |
| LTM Sep 2026 | $170.96M USD | +89.1% | -14.5% | |
| LTM Mar 2026 | $149.89M USD | +13.3% | +19.6% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $81.84M USD | +6.9% | — |
| LTM Mar 2026 | $76.98M USD | +25.6% | +11.9% | |
| LTM Mar 2026 | $40.36M USD | +8712.9% | +115.9% | |
| LTM Mar 2026 | $1.41M USD | +607.6% | +24.8% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥0 CNY | -100.0% | — |
| Peer median (excluding AMBQ) | — | +17.8% | +11.9% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 50.97M | 91.01M | 65.54M | 76.07M | 72.51M |
| Cost of Revenue | 29.4M | 60.24M | 46.1M | 51.78M | 46.82M |
| Gross Profit | 21.57M | 30.77M | 19.44M | 24.29M | 25.7M |
| Gross Margin | 42.3% | 33.8% | 29.7% | 31.9% | 35.4% |
| Research & Development | 27.79M | 36.11M | 44.02M | 37.17M | 33.69M |
| Selling, General & Admin | 14M | 19.13M | 26.74M | 27.74M | 33.15M |
| Operating Expenses | 41.79M | 55.87M | 70.76M | 64.9M | 66.84M |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| EBITDA | (18.29M) | (21.85M) | (42.59M) | (33.39M) | (29.21M) |
| EBITDA Margin | -35.9% | -24.0% | -65.0% | -43.9% | -40.3% |
| Operating Income | (20.22M) | (25.1M) | (51.32M) | (40.61M) | (41.14M) |
| Operating Margin | -39.7% | -27.6% | -78.3% | -53.4% | -56.7% |
| Interest Income | 0 | 43K | 0 | 0 | 0 |
| Interest Expense | 4.58M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (4.98M) | (216K) | 1.02M | 980K | 4.72M |
| Income Before Tax | (25.2M) | (25.32M) | (50.3M) | (39.63M) | (36.42M) |
| Pre-Tax Margin | -49.4% | -27.8% | -76.8% | -52.1% | -50.2% |
| Income Tax Expense | 25K | 25K | 30K | 28K | 40K |
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Net Margin | -49.5% | -27.8% | -76.8% | -52.1% | -50.3% |
| EPS (Basic) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| EPS (Diluted) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| Weighted Avg Shares | 13.61M | 248.89M | 10.45M | 13.54M | 7.98M |
| Weighted Avg Shares (Diluted) | 13.61M | 248.89M | 10.45M | 13.61M | 7.98M |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.